Jun 15, 2009 11:07am EDT OPKO Invests in Biotechnology Company with Novel Approach to Developing New Drugs
Jun 12, 2009 8:30am EDT Jamie Freedman, M.D., Ph.D. Joins OPKO Health as Executive Vice President of R&D and Business Development
Feb 10, 2009 12:15pm EST OPKO To Present Data on Next Generation Anti-Angiogenic VEGF165b-Sparing siRNA at Association for Research and Vision in Ophthalmology (ARVO 2009) Meeting
Jan 23, 2009 9:13am EST OPKO Receives FDA 510(k) Clearance for Spectral OCT SLO Combination Imaging System
Dec 04, 2008 9:16am EST OPKO Health Announces Completion of Enrollment for Its Phase III Clinical Trial of Bevasiranib for Treatment of AMD